{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:08:00Z","timestamp":1794002880990,"version":"4.8.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Numerous risk factors for mental disorders have been identified. However, we do not know how many disorders we could prevent\u00a0and to what extent by modifying these risk\u00a0factors. This study quantifies the Population Attributable Fraction (PAF) of potentially modifiable risk factors for mental disorders. We conducted a PRISMA 2020-compliant (Protocol:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/osf.io\/hk2ag\">https:\/\/osf.io\/hk2ag<\/jats:ext-link>\n                    ) meta-umbrella systematic review (Web of Science\/PubMed\/Cochrane Central Register of Reviews\/Ovid\/PsycINFO, until 05\/12\/2021) of umbrella reviews reporting associations between potentially modifiable risk factors and ICD\/DSM mental disorders, restricted to highly convincing (class I) and convincing (class II) evidence from prospective cohorts. The primary outcome was the global meta-analytical PAF, complemented by sensitivity analyses across different settings, the meta-analytical Generalised Impact Fraction (GIF), and study quality assessment (AMSTAR). Seven umbrella reviews (including 295 meta-analyses and 547 associations) identified 28 class I\u2013II risk associations (23 risk factors; AMSTAR: 45.0% high-, 35.0% medium-, 20.0% low quality). The largest global PAFs not confounded by indication were 37.84% (95% CI\u2009=\u200926.77\u201348.40%) for childhood adversities and schizophrenia spectrum disorders, 24.76% (95% CI\u2009=\u200913.98\u201336.49%) for tobacco smoking and opioid use disorders, 17.88% (95% CI\u2009=\u2009not available) for job strain and depression, 14.60% (95% CI\u2009=\u20099.46\u201320.52%) for insufficient physical activity and Alzheimer\u2019s disease, 13.40% (95% CI\u2009=\u20097.75\u201320.15%) for childhood sexual abuse and depressive disorders, 12.37% (95% CI\u2009=\u20095.37\u201325.34%) for clinical high-risk state for psychosis and any non-organic psychotic disorders, 10.00% (95% CI\u2009=\u20095.62\u201315.95%) for three metabolic factors and depression, 9.73% (95% CI\u2009=\u20094.50\u201317.30%) for cannabis use and schizophrenia spectrum disorders, and 9.30% (95% CI\u2009=\u20097.36\u201311.38%) for maternal pre-pregnancy obesity and ADHD. The GIFs confirmed the preventive capacity for these factors. Addressing several potentially modifiable risk factors, particularly childhood adversities, can reduce the global population-level incidence of mental disorders.\n                  <\/jats:p>","DOI":"10.1038\/s41380-022-01586-8","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T01:02:56Z","timestamp":1651107776000},"page":"3510-3519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9019-4125","authenticated-orcid":false,"given":"Elena","family":"Dragioti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Radua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-7233","authenticated-orcid":false,"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3382-4754","authenticated-orcid":false,"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8920-3407","authenticated-orcid":false,"given":"Dominic","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0387-880X","authenticated-orcid":false,"given":"Peter B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2326-1820","authenticated-orcid":false,"given":"Jae","family":"Il Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3582-6788","authenticated-orcid":false,"given":"Paolo","family":"Fusar-Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"1586_CR1","doi-asserted-by":"crossref","unstructured":"Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27:281\u201395.","DOI":"10.1038\/s41380-021-01161-7"},{"key":"1586_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S2215-0366(18)30057-9","volume":"5","author":"C Arango","year":"2018","unstructured":"Arango C, Diaz-Caneja CM, McGorry PD, Rapoport J, Sommer IE, Vorstman JA, et al. Preventive strategies for mental health. Lancet Psychiatry. 2018;5:591\u2013604.","journal-title":"Lancet Psychiatry"},{"key":"1586_CR3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/wps.20869","volume":"20","author":"P Fusar-Poli","year":"2021","unstructured":"Fusar-Poli P, Correll CU, Arango C, Berk M, Patel V, Ioannidis JPA. Preventive psychiatry: a blueprint for improving the mental health of young people. World Psychiatry. 2021;20:200\u201321.","journal-title":"World Psychiatry"},{"key":"1586_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamapsychiatry.2019.4779","volume":"77","author":"P Fusar-Poli","year":"2020","unstructured":"Fusar-Poli P, Salazar de Pablo G, Correll CU, Meyer-Lindenberg A, Millan MJ, Borgwardt S, et al. Prevention of psychosis: advances in detection, prognosis, and intervention. JAMA Psychiatry. 2020;77:755\u201365.","journal-title":"JAMA Psychiatry"},{"key":"1586_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/schbul\/sbw158","volume":"43","author":"P Fusar-Poli","year":"2017","unstructured":"Fusar-Poli P. The clinical high-risk state for psychosis (CHR-P), version II. Schizophr Bull. 2017;43:44\u201347.","journal-title":"Schizophr Bull"},{"key":"1586_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/jamapsychiatry.2019.3561","volume":"77","author":"G Salazar de Pablo","year":"2020","unstructured":"Salazar de Pablo G, Catalan A, Fusar-Poli P. Clinical validity of DSM-5 attenuated psychosis syndrome: advances in diagnosis, prognosis, and treatment. JAMA Psychiatry. 2020;77:311\u201320.","journal-title":"JAMA Psychiatry"},{"key":"1586_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.euroneuro.2020.10.007","volume":"41","author":"G Salazar de Pablo","year":"2020","unstructured":"Salazar de Pablo G, De Micheli A, Nieman DH, Correll CU, Kessing LV, Pfennig A, et al. Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysis. Eur Neuropsychopharmacol. 2020;41:28\u201339.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1586_CR8","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.euroneuro.2019.09.006","volume":"29","author":"P Fusar-Poli","year":"2019","unstructured":"Fusar-Poli P, Bauer M, Borgwardt S, Bechdolf A, Correll CU, Do KQ, et al. European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP). Eur Neuropsychopharmacol. 2019;29:1301\u201311.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1586_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/jcpp.13322","volume":"62","author":"A Catalan","year":"2021","unstructured":"Catalan A, Salazar de Pablo G, Vaquerizo Serrano J, Mosillo P, Baldwin H, Fernandez-Rivas A, et al. Annual research review: prevention of psychosis in adolescents\u2014systematic review and meta-analysis of advances in detection, prognosis and intervention. J Child Psychol Psychiatry. 2021;62:657\u201373.","journal-title":"J Child Psychol Psychiatry"},{"key":"1586_CR10","first-page":"191","volume":"30","author":"EG Clark","year":"1954","unstructured":"Clark EG. Natural history of syphilis and levels of prevention. Br J Vener Dis. 1954;30:191\u20137.","journal-title":"Br J Vener Dis"},{"key":"1586_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamapsychiatry.2020.3049","volume":"78","author":"NR Wray","year":"2021","unstructured":"Wray NR, Lin T, Austin J, McGrath JJ, Hickie IB, Murray GK, et al. From basic science to clinical application of polygenic risk scores: a primer. JAMA Psychiatry. 2021;78:101\u20139.","journal-title":"JAMA Psychiatry"},{"key":"1586_CR12","doi-asserted-by":"crossref","unstructured":"Trubetskoy V, Pardi\u00f1as AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al.Schizophrenia Working Group of the Psychiatric Genomics Consortium. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502\u20138.","DOI":"10.1038\/s41586-022-04434-5"},{"key":"1586_CR13","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/schbul\/sbaa086","volume":"46","author":"A Marsman","year":"2020","unstructured":"Marsman A, Pries LK, Ten Have M, de Graaf R, van Dorsselaer S, Bak M, et al. Do current measures of polygenic risk for mental disorders contribute to population variance in mental health? Schizophr Bull. 2020;46:1353\u201362.","journal-title":"Schizophr Bull"},{"key":"1586_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/wps.20436","volume":"16","author":"R Uher","year":"2017","unstructured":"Uher R, Zwicker A. Etiology in psychiatry: embracing the reality of poly-gene-environmental causation of mental illness. World Psychiatry. 2017;16:121\u20139.","journal-title":"World Psychiatry"},{"key":"1586_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/ebmental-2018-300014","volume":"21","author":"P Fusar-Poli","year":"2018","unstructured":"Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evid Based Ment Health. 2018;21:95\u2013100.","journal-title":"Evid Based Ment Health"},{"key":"1586_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1503\/cmaj.081086","volume":"181","author":"JP Ioannidis","year":"2009","unstructured":"Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. Cmaj. 2009;181:488\u201393.","journal-title":"Cmaj"},{"key":"1586_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/wps.20490","volume":"17","author":"J Radua","year":"2018","unstructured":"Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, Phiphopthatsanee N, Amir T, et al. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry. 2018;17:49\u201366.","journal-title":"World Psychiatry"},{"key":"1586_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","volume":"13","author":"E Aromataris","year":"2015","unstructured":"Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Health. 2015;13:132\u201340.","journal-title":"Int J Evid Based Health"},{"key":"1586_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.12.008","volume":"23","author":"V Bellou","year":"2016","unstructured":"Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP. Environmental risk factors and Parkinson\u2019s disease: an umbrella review of meta-analyses. Parkinsonism Relat Disord. 2016;23:1\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"1586_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1352458519872664","volume":"26","author":"L Belbasis","year":"2020","unstructured":"Belbasis L, Bellou V, Evangelou E, Tzoulaki I. Environmental factors and risk of multiple sclerosis: findings from meta-analyses and Mendelian randomization studies. Mult Scler. 2020;26:397\u2013404.","journal-title":"Mult Scler"},{"key":"1586_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1474-4422(14)70267-4","volume":"14","author":"L Belbasis","year":"2015","unstructured":"Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14:263\u201373.","journal-title":"Lancet Neurol"},{"key":"1586_CR22","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jamapsychiatry.2019.2859","volume":"76","author":"E Dragioti","year":"2019","unstructured":"Dragioti E, Solmi M, Favaro A, Fusar-Poli P, Dazzan P, Thompson T, et al. Association of antidepressant use with adverse health outcomes: a systematic umbrella review. JAMA Psychiatry. 2019;76:1241\u201355.","journal-title":"JAMA Psychiatry"},{"key":"1586_CR23","doi-asserted-by":"publisher","first-page":"g2035","DOI":"10.1136\/bmj.g2035","volume":"348","author":"E Theodoratou","year":"2014","unstructured":"Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035.","journal-title":"BMJ"},{"key":"1586_CR24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jamapsychiatry.2018.2530","volume":"75","author":"P Fusar-Poli","year":"2018","unstructured":"Fusar-Poli P, Hijazi Z, Stahl D, Steyerberg EW. The science of prognosis in psychiatry: a review. JAMA Psychiatry. 2018;75:1289\u201397.","journal-title":"JAMA Psychiatry"},{"key":"1586_CR25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41416-018-0062-5","volume":"118","author":"F Bray","year":"2018","unstructured":"Bray F, Soerjomataram I. Population attributable fractions continue to unmask the power of prevention. Br J Cancer. 2018;118:1031\u20132.","journal-title":"Br J Cancer"},{"key":"1586_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40471-016-0085-5","volume":"3","author":"KD Shield","year":"2016","unstructured":"Shield KD, Parkin DM, Whiteman DC, Rehm J, Viallon V, Micallef CM, et al. Population attributable and preventable fractions: cancer risk factor surveillance, and cancer policy projection. Curr Epidemiol Rep. 2016;3:201\u201311.","journal-title":"Curr Epidemiol Rep."},{"key":"1586_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1753-6405.12471","volume":"39","author":"DC Whiteman","year":"2015","unstructured":"Whiteman DC, Webb PM, Green AC, Neale RE, Fritschi L, Bain CJ, et al. Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions. Aust N. Z J Public Health. 2015;39:477\u201384.","journal-title":"Aust N. Z J Public Health"},{"key":"1586_CR28","doi-asserted-by":"crossref","unstructured":"Rezende LF, Eluf-Neto J. Population attributable fraction: planning of diseases prevention actions in Brazil. Rev Saude Publica 2016;50:30.","DOI":"10.1590\/S1518-8787.2016050006269"},{"key":"1586_CR29","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1016\/S2214-109X(19)30074-9","volume":"7","author":"N Mukadam","year":"2019","unstructured":"Mukadam N, Sommerlad A, Huntley J, Livingston G. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data. Lancet Glob Health. 2019;7:e596\u2013e603.","journal-title":"Lancet Glob Health"},{"key":"1586_CR30","doi-asserted-by":"publisher","first-page":"k757","DOI":"10.1136\/bmj.k757","volume":"360","author":"MA Mansournia","year":"2018","unstructured":"Mansournia MA, Altman DG. Population attributable fraction. BMJ. 2018;360:k757.","journal-title":"BMJ"},{"key":"1586_CR31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.neubiorev.2021.02.016","volume":"124","author":"J Radua","year":"2021","unstructured":"Radua J. PRISMA 2020\u2014an updated checklist for systematic reviews and meta-analyses. Neurosci Biobehav Rev. 2021;124:324\u20135.","journal-title":"Neurosci Biobehav Rev"},{"key":"1586_CR32","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1586_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01873-7","volume":"19","author":"AA Mentis","year":"2021","unstructured":"Mentis AA, Dardiotis E, Efthymiou V, Chrousos GP. Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews. BMC Med. 2021;19:6.","journal-title":"BMC Med"},{"key":"1586_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/schbul\/sbt114","volume":"40","author":"D Rasic","year":"2014","unstructured":"Rasic D, Hajek T, Alda M, Uher R. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies. Schizophr Bull. 2014;40:28\u201338.","journal-title":"Schizophr Bull"},{"key":"1586_CR35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ajmg.b.32640","volume":"177","author":"EJ Pepper","year":"2018","unstructured":"Pepper EJ, Pathmanathan S, McIlrae S, Rehman FU, Cardno AG. Associations between risk factors for schizophrenia and concordance in four monozygotic twin samples. Am J Med Genet B Neuropsychiatr Genet. 2018;177:503\u201310.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1586_CR36","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"1586_CR37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jalz.2016.07.152","volume":"13","author":"V Bellou","year":"2017","unstructured":"Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JPA, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. 2017;13:406\u201318.","journal-title":"Alzheimers Dement"},{"key":"1586_CR38","doi-asserted-by":"publisher","first-page":"e12982","DOI":"10.1111\/eci.12982","volume":"48","author":"M Solmi","year":"2018","unstructured":"Solmi M, Kohler CA, Stubbs B, Koyanagi A, Bortolato B, Monaco F, et al. Environmental risk factors and nonpharmacological and nonsurgical interventions for obesity: An umbrella review of meta-analyses of cohort studies and randomized controlled trials. Eur J Clin Invest. 2018;48:e12982.","journal-title":"Eur J Clin Invest"},{"key":"1586_CR39","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2016.16435","volume":"316","author":"DN Kyriacou","year":"2016","unstructured":"Kyriacou DN, Lewis RJ. Confounding by indication in clinical research. J Am Med Assoc. 2016;316:1818\u20139.","journal-title":"J Am Med Assoc"},{"key":"1586_CR40","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.","journal-title":"BMJ"},{"key":"1586_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"Collaborators GBDO, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl J Med. 2017;377:13\u201327.","journal-title":"N. Engl J Med"},{"key":"1586_CR42","doi-asserted-by":"publisher","first-page":"e76635","DOI":"10.1371\/journal.pone.0076635","volume":"8","author":"L Degenhardt","year":"2013","unstructured":"Degenhardt L, Ferrari AJ, Calabria B, Hall WD, Norman RE, McGrath J, et al. The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLoS ONE. 2013;8:e76635.","journal-title":"PLoS ONE"},{"key":"1586_CR43","doi-asserted-by":"crossref","unstructured":"Reitsma MB, Flor LS, Mullany EC, Gupta V, Hay SI, Gakidou E. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and initiation among young people in 204 countries and territories, 1990\u20132019. The Lancet Public Health. 2021;6:e472\u201381.","DOI":"10.1016\/S2468-2667(21)00102-X"},{"key":"1586_CR44","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S2215-0366(21)00040-7","volume":"8","author":"DF Santomauro","year":"2021","unstructured":"Santomauro DF, Melen S, Mitchison D, Vos T, Whiteford H, Ferrari AJ. The hidden burden of eating disorders: an extension of estimates from the Global Burden of Disease Study 2019. Lancet Psychiatry. 2021;8:320\u20138.","journal-title":"Lancet Psychiatry"},{"key":"1586_CR45","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","journal-title":"Lancet"},{"key":"1586_CR46","unstructured":"Obesity WHOCo, World Health O. Obesity: preventing and managing the global epidemic: report of a WHO consultation. Geneva: World Health Organization; 2000."},{"key":"1586_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","volume":"3","author":"Z Munn","year":"2014","unstructured":"Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3:123\u20138.","journal-title":"Int J Health Policy Manag"},{"key":"1586_CR48","first-page":"531","volume":"9","author":"ML Levin","year":"1953","unstructured":"Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953;9:531\u201341.","journal-title":"Acta Unio Int Contra Cancrum"},{"key":"1586_CR49","doi-asserted-by":"crossref","unstructured":"Lin C-K, Chen S-T. Estimation and application of population attributable fraction in ecological studies. Environmental Health. 2019;18:1\u20133.","DOI":"10.1186\/s12940-019-0492-4"},{"key":"1586_CR50","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF. What\u2019s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. J Am Med Assoc. 1998;280:1690\u20131.","journal-title":"J Am Med Assoc"},{"key":"1586_CR51","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/oxfordjournals.aje.a009523","volume":"147","author":"LE Daly","year":"1998","unstructured":"Daly LE. Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol. 1998;147:783\u201390.","journal-title":"Am J Epidemiol"},{"key":"1586_CR52","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/BF01318961","volume":"7","author":"H Morgenstern","year":"1982","unstructured":"Morgenstern H, Bursic ES. A method for using epidemiologic data to estimate the potential impact of an intervention on the health status of a target population. J Community Health. 1982;7:292\u2013309.","journal-title":"J Community Health"},{"key":"1586_CR53","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/acps.12847","volume":"137","author":"L Belbasis","year":"2018","unstructured":"Belbasis L, Kohler CA, Stefanis N, Stubbs B, van Os J, Vieta E, et al. Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses. Acta Psychiatr Scand. 2018;137:88\u201397.","journal-title":"Acta Psychiatr Scand"},{"key":"1586_CR54","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jpsychires.2018.05.020","volume":"103","author":"CA Kohler","year":"2018","unstructured":"Kohler CA, Evangelou E, Stubbs B, Solmi M, Veronese N, Belbasis L, et al. Mapping risk factors for depression across the lifespan: an umbrella review of evidence from meta-analyses and Mendelian randomization studies. J Psychiatr Res. 2018;103:189\u2013207.","journal-title":"J Psychiatr Res"},{"key":"1586_CR55","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S2215-0366(19)30181-6","volume":"6","author":"JY Kim","year":"2019","unstructured":"Kim JY, Son MJ, Son CY, Radua J, Eisenhut M, Gressier F, et al. Environmental risk factors and biomarkers for autism spectrum disorder: an umbrella review of the evidence. Lancet Psychiatry. 2019;6:590\u2013600.","journal-title":"Lancet Psychiatry"},{"key":"1586_CR56","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S2215-0366(20)30312-6","volume":"7","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kim JY, Lee J, Jeong GH, Lee E, Lee S, et al. Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review. Lancet Psychiatry. 2020;7:955\u201370.","journal-title":"Lancet Psychiatry"},{"key":"1586_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neubiorev.2021.03.014","volume":"126","author":"M Solmi","year":"2021","unstructured":"Solmi M, Dragioti E, Croatto G, Radua J, Borgwardt S, Carvalho AF, et al. Risk and protective factors for cannabis, cocaine, and opioid use disorders: an umbrella review of meta-analyses of observational studies. Neurosci Biobehav Rev. 2021;126:243\u201351.","journal-title":"Neurosci Biobehav Rev"},{"key":"1586_CR58","doi-asserted-by":"publisher","first-page":"m3048","DOI":"10.1136\/bmj.m3048","volume":"371","author":"CA Nelson","year":"2020","unstructured":"Nelson CA, Scott RD, Bhutta ZA, Harris NB, Danese A, Samara M. Adversity in childhood is linked to mental and physical health throughout life. BMJ. 2020;371:m3048.","journal-title":"BMJ"},{"key":"1586_CR59","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/0803706X.2013.778422","volume":"24","author":"LA Kirshner","year":"2013","unstructured":"Kirshner LA. Trauma and psychosis: a review and framework for psychoanalytic understanding. Int Forum Psychoanalysis. 2013;24:216\u201324.","journal-title":"Int Forum Psychoanalysis"},{"key":"1586_CR60","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1192\/apt.bp.116.015891","volume":"23","author":"H Coughlan","year":"2018","unstructured":"Coughlan H, Cannon M. Does childhood trauma play a role in the aetiology of psychosis? A review of recent evidence. BJPsych Adv. 2018;23:307\u201315.","journal-title":"BJPsych Adv"},{"key":"1586_CR61","unstructured":"Rosenfield PJ, Jiang D, Pauselli L. Childhood adversity and psychotic disorders: epidemiological evidence, theoretical models and clinical considerations. Schizophr Res. 2021;S0920-9964:00217\u20136."},{"key":"1586_CR62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/acps.13268","volume":"143","author":"MT McKay","year":"2021","unstructured":"McKay MT, Cannon M, Chambers D, Conroy RM, Coughlan H, Dodd P, et al. Childhood trauma and adult mental disorder: A systematic review and meta-analysis of longitudinal cohort studies. Acta Psychiatr Scand. 2021;143:189\u2013205.","journal-title":"Acta Psychiatr Scand"},{"key":"1586_CR63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.schres.2016.06.005","volume":"176","author":"A Egerton","year":"2016","unstructured":"Egerton A, Valmaggia LR, Howes OD, Day F, Chaddock CA, Allen P, et al. Adversity in childhood linked to elevated striatal dopamine function in adulthood. Schizophr Res. 2016;176:171\u20136.","journal-title":"Schizophr Res"},{"key":"1586_CR64","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00127-019-01810-x","volume":"55","author":"MS Farris","year":"2020","unstructured":"Farris MS, Shakeel MK, Addington J. Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review. Soc Psychiatry Psychiatr Epidemiol. 2020;55:527\u201337.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"1586_CR65","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.addbeh.2018.11.043","volume":"92","author":"A Rajabi","year":"2019","unstructured":"Rajabi A, Dehghani M, Shojaei A, Farjam M, Motevalian SA. Association between tobacco smoking and opioid use: a meta-analysis. Addict Behav. 2019;92:225\u201335.","journal-title":"Addict Behav"},{"key":"1586_CR66","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.drugalcdep.2018.01.024","volume":"186","author":"MA Parker","year":"2018","unstructured":"Parker MA, Streck JM, Sigmon SC. Associations between opioid and nicotine dependence in nationally representative samples of United States adult daily smokers. Drug Alcohol Depend. 2018;186:167\u201370.","journal-title":"Drug Alcohol Depend"},{"key":"1586_CR67","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/00952990.2016.1209513","volume":"43","author":"SJ Kohut","year":"2017","unstructured":"Kohut SJ. Interactions between nicotine and drugs of abuse: a review of preclinical findings. Am J Drug Alcohol Abus. 2017;43:155\u201370.","journal-title":"Am J Drug Alcohol Abus"},{"key":"1586_CR68","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1017\/S003329171600355X","volume":"47","author":"IEH Madsen","year":"2017","unstructured":"Madsen IEH, Nyberg ST, Magnusson Hanson LL, Ferrie JE, Ahola K, Alfredsson L, et al. Job strain as a risk factor for clinical depression: systematic review and meta-analysis with additional individual participant data. Psychol Med. 2017;47:1342\u201356.","journal-title":"Psychol Med"},{"key":"1586_CR69","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/obr.12725","volume":"19","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, Sakuraya A, Kawakami N, Imamura K, Ando E, Asai Y, et al. Work-related psychosocial factors and metabolic syndrome onset among workers: a systematic review and meta-analysis. Obes Rev. 2018;19:1557\u201368.","journal-title":"Obes Rev"},{"key":"1586_CR70","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/EDE.0000000000000666","volume":"28","author":"N Dragano","year":"2017","unstructured":"Dragano N, Siegrist J, Nyberg ST, Lunau T, Fransson EI, Alfredsson L, et al. Effort-reward imbalance at work and incident coronary heart disease: a multicohort study of 90,164 individuals. Epidemiology. 2017;28:619\u201326.","journal-title":"Epidemiology"},{"key":"1586_CR71","doi-asserted-by":"publisher","first-page":"e0159978","DOI":"10.1371\/journal.pone.0159978","volume":"11","author":"H Sui","year":"2016","unstructured":"Sui H, Sun N, Zhan L, Lu X, Chen T, Mao X. Association between work-related stress and risk for type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. PLoS ONE. 2016;11:e0159978.","journal-title":"PLoS ONE"},{"key":"1586_CR72","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/STROKEAHA.114.008019","volume":"46","author":"EI Fransson","year":"2015","unstructured":"Fransson EI, Nyberg ST, Heikkila K, Alfredsson L, Bjorner JB, Borritz M, et al. Job strain and the risk of stroke: an individual-participant data meta-analysis. Stroke. 2015;46:557\u20139.","journal-title":"Stroke"},{"key":"1586_CR73","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.puhe.2019.11.023","volume":"181","author":"S Amiri","year":"2020","unstructured":"Amiri S, Behnezhad S. Is job strain a risk factor for musculoskeletal pain? A systematic review and meta-analysis of 21 longitudinal studies. Public Health. 2020;181:158\u201367.","journal-title":"Public Health"},{"key":"1586_CR74","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.puhe.2019.10.030","volume":"181","author":"S Amiri","year":"2020","unstructured":"Amiri S, Behnezhad S. Job strain and mortality ratio: a systematic review and meta-analysis of cohort studies. Public Health. 2020;181:24\u201333.","journal-title":"Public Health"},{"key":"1586_CR75","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1473-3099(19)30618-8","volume":"20","author":"S Mishra","year":"2020","unstructured":"Mishra S, Baral SD. Rethinking the population attributable fraction for infectious diseases. Lancet Infect Dis. 2020;20:155\u20137.","journal-title":"Lancet Infect Dis"},{"key":"1586_CR76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.05.017","volume":"92","author":"T Hanc","year":"2018","unstructured":"Hanc T, Cortese S. Attention deficit\/hyperactivity-disorder and obesity: a review and model of current hypotheses explaining their comorbidity. Neurosci Biobehav Rev. 2018;92:16\u201328.","journal-title":"Neurosci Biobehav Rev"},{"key":"1586_CR77","unstructured":"Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd edn. Philadelphia: Wolters Kluwer Health; 2015, p 1 online resource (768 p.)."},{"key":"1586_CR78","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.annepidem.2014.11.005","volume":"25","author":"S Greenland","year":"2015","unstructured":"Greenland S. Concepts and pitfalls in measuring and interpreting attributable fractions, prevented fractions, and causation probabilities. Ann Epidemiol. 2015;25:155\u201361.","journal-title":"Ann Epidemiol"},{"key":"1586_CR79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/sextrans-2013-051250","volume":"90","author":"S Mishra","year":"2014","unstructured":"Mishra S, Pickles M, Blanchard JF, Moses S, Boily MC. Distinguishing sources of HIV transmission from the distribution of newly acquired HIV infections: why is it important for HIV prevention planning? Sex Transm Infect. 2014;90:19\u201325.","journal-title":"Sex Transm Infect"},{"key":"1586_CR80","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.annepidem.2016.06.004","volume":"26","author":"S Mishra","year":"2016","unstructured":"Mishra S, Boily MC, Schwartz S, Beyrer C, Blanchard JF, Moses S, et al. Data and methods to characterize the role of sex work and to inform sex work programs in generalized HIV epidemics: evidence to challenge assumptions. Ann Epidemiol. 2016;26:557\u201369.","journal-title":"Ann Epidemiol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01586-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01586-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T05:04:34Z","timestamp":1680843874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-022-01586-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":80,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1586"],"URL":"https:\/\/doi.org\/10.1038\/s41380-022-01586-8","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"29 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Arango has been a consultant to or has received honoraria or grants from Acadia, Angelini, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda outside the current work. Paolo Fusar-Poli has received research or personal fees from Lundbeck, Angelini, Menarini and Boehringer Ingelheim outside the current work. Dr. Correll has been a consultant and\/or advisor to or has received honoraria from AbbVie, Acadia, Alkermes, Allergan, Angelini, Aristo, Axsome, Damitsa, Gedeon Richter, Hikma, IntraCellular Therapies, Janssen\/J&J, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Medscape, Merck, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Rovi, Servier, SK Life Science, Sumitomo Dainippon, Sunovion, Supernus, Takeda, Teva, and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Lundbeck, Rovi, Supernus, and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of LB Pharma. Dr. Jones is funded by the NIHR ARC East of England. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}